Flora Peyvandi Shares BIC 2025 Coverage of Hemostasis & Thrombosis: 10 Posts Not To Miss
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
Flora Peyvandi shared BIC 2025 Coverage of latest research on Hemostasis and Thrombosis fresh from the conference:
1.‘‘Wolfgang Miesbach reports the safety of HA and HB gene therapies after 5 and 4 years respectively”
2.”David Lilicrap reports the interindividual variability of gene therapy in Hemophilia at BIC2025”
3.‘‘David Lilicrap reports data on long term safety of HA gene therapy”
4.”Alessio Cantore at Bic 2025 reporting where we are standing with lentiviral gene therapy in Hemophilia”
5.”Naldini group showed clearly they are ready to go through clinical trial phase 1 for HB with lenti viral vector and what’s missing is Funding.
Why that’s happening? No more interest in GT in Hemophilia even for the cure?”
6.”Very interesting data on gene therapy as the ITI to reverse the anti factor inhibitors in mice with anti FIX inhibitors was successful bic 2025.
Data from Dr Herzog Indiana University”
7.”New gene therapy clinical trial on FVII severe deficiency by Amit Nathwani. Look forward for that!”
8.”Amy Shapiro reports a new DDAP molecule to treat patients with VWD type 1.
This is a great news due to discontinuation of intranasal Desmopressin and it shortage.
This formulation is available in US”
9.”A single dose of VGA039 in 10 patients with VWD inhibiting PS , showed good efficacy with no safety issue reported by Carolyn Millar”
10.”Michela Milani should how they created a shielded lentiviral vector to reduce the immunogenicity against FVIII in mice”
More from BIC 2025 featured in Hemostasis Today.
-
Mar 20, 2026, 16:22Welcoming Samer Al Hadidi to the Blood Cancers Team – UT Southwestern Simmons Cancer Center
-
Mar 20, 2026, 16:21Maxime Dely: The Lifesaving Power of Plasma Donations
-
Mar 20, 2026, 16:20Yves Bikorimana: Hemolysis – Why It Ruins Laboratory Results
-
Mar 20, 2026, 16:19Simon Senanu: G6PD Deficiency Testing – What the Lab Must Get Right
-
Mar 20, 2026, 16:18Khaled Elshazly: Can We Stop Chemotherapy-Induced Thrombocytopenia from Delaying Treatment?
-
Mar 20, 2026, 15:50Rithwic Mani: Platelet-to-Lymphocyte Ratio as A Simple and Cost-Effective Prognostic Biomarker in Stroke
-
Mar 20, 2026, 15:46Umberto Pensato: Presenting ESCAPE-MeVO Trial’s Practice-Changing Results at ESOC 2026
-
Mar 20, 2026, 15:42Varun Bafna: The Power of Extended Half-Life Factor IX in Enabling Safe Major Surgeries
-
Mar 20, 2026, 15:31Stuart Allan: An Important Translational Project In Relation to Acute Stroke Treatment